Logo

Zydus Lifesciences Ltd. Share Price

Pharmaceuticals & Drugs

Zydus Lifesciences Ltd. (INR)958.30.6   (0.1%)

Exchange ScripsBSE532321NSEZYDUSLIFEISININE010B01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Zydus Lifesciences Ltd. Performance

Market performance

Open price951
High965.3
Volumes1016691
Prev Close958.3
Low949.25
Closing date2025-06-18

Historical performance

1 Year High1324.30
3 Year High1324.30
5 Year High1324.30
1 Year Low795.00
3 Year Low329.80
5 Year Low319.00

Zydus Lifesciences Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
NaN
Face Value
Face Value (₹)
P/E Ratio
P/E Ratio
Dividend Yield
Dividend Yield
N/A

Zydus Lifesciences Ltd. Investment Returns

1 Year
-11.2%
3 Years
185.5%
5 Years
162.1%
10 Years
168.5%

Zydus Lifesciences Ltd. Technicals

IndicatorsValueSignal
5-DMA968.82Bearish
10-DMA969.42Bearish
20-DMA945.17Bullish
50-DMA903.3Bullish
100-DMA911.38Bullish
200-DMA963.3Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters128888
Foreign Investors---------------
Domestic Investors128888
Public Investors371607365348370855336301294316
Government33233

Zydus Lifesciences Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income369447463907750
Operating Profit56684404653565434603
Interest812129912701864
Depreciation7641722771306696
Profit Before Tax48089258972838123992
Consolidated Net Profit38595196034487321336
Adjusted EPS38194421

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1006101210241024
Total Reserves197289174146168972128899
Minority Interest22721217252054219373
Total Non-Current Liabilities1931-7250-1936194
Total Liabilities276366244940266996228103
Capital Work in Progress111151130266107832
Total Assets276366244940266996228103

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities32279268882104532939
Cash Flow from Investing Activities-1475215350-10003-7246
Cash Flow from Financing Activitie-18104-44004-8683-25477
Net Cash Inflow / Outflow-577-17662359216
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 24.98.
  • 3Y Stock Price CAGR of the stock is 42.0.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹56684 Million.
  • The company generated revenue of ₹195474 Million in the previous financial year.

Zydus Lifesciences Ltd.

958.30.6   (0.1%)

Investment Amount: ₹ 1000000
Current Value: ₹ 892645.9
No. of Shares: 931.5
Performance:-10.7%
P/L: ₹-107354.1

Top Gainers

SymbolChange%
EMIL158.37(18%)
SILLYMONKS18(14%)
OPTIEMUS684.6(11%)
AAKASH9.7(11%)
PFOCUS130.98(10%)

Top Losers

SymbolChange%
ORIENTCEM253.7(-16%)
KBCGLOBAL0.55(-11%)
SHAH4.45(-10%)
MOBIKWIK244.85(-9%)
HAVISHA2.29(-9%)
SGL16.62(-9%)
IKS1703.4(-8%)
STLTECH104.55(-7%)

Similar stocks

Ind-Swift Laboratories Ltd.

45.1

103.35

May 18 - June 18

Onesource Specialty Pharma Ltd.

37.5

2195

May 18 - June 18

Concord Biotech Ltd.

34

2008.9

May 18 - June 18

Pfizer Ltd.

31.3

5792.5

May 18 - June 18

Shilpa Medicare Ltd.

29.7

917.9

May 18 - June 18

Wockhardt Ltd.

29.2

1718.5

May 18 - June 18

Strides Pharma Science Ltd.

29.1

853.8

May 18 - June 18

Venus Remedies Ltd.

26.6

433.95

May 18 - June 18

Announcing Stock of the Month!

Stock of the Month
Stock of the Month